Anti-Cytokeratin 19 抗体 [BA-17]
Anti-Cytokeratin 19 antibody [BA-17]
- KO Validated
- 詳細を見る
4
(5 Reviews)
|
(28 Publications)
Mouse Monoclonal Cytokeratin 19 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 28 publications. Immunogen corresponding to Tissue preparation containing KRT19 protein.
別名を表示する
Cytokeratin-19, Keratin-19, CK-19, K19, KRT19, ck19, ck 19
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
Separation of MCF-7 cells (red-filled) from human leukocytes (black-dashed) in flow cytometry analysis (intracellular staining) of peripheral whole blood spiked with MCF-7 cells stained using ab7755 (concentration in sample 3 μg/ml, GAM APC).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
Human normal skin. Staining is observed in the cytoplasm (epidermal basal cells). Left panel : with primary antibody at 2 ug/ml. Right panel : isotype control. Sections were stained using an automated system DAKO Autostainer Plus , at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for mouse for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
Overlay histogram showing MCF7 cells stained with ab7755 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab7755, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in MCF7 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- ICC
Supplier Data
Immunocytochemistry - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
ab7755 staining Cytokeratin 19 in wild-type MCF7 cells (top panel) and KRT19 knockout MCF7 cells (bottom panel). The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab7755 at 5μg/ml concentration and ab6046 (Rabbit polyclonal to beta Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to mouse IgG (Alexa Fluor® 488) (ab150117) at 2 μg/ml (shown in green) and a goat secondary antibody to rabbit IgG (Alexa Fluor® 594) (ab150080) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
ICC/IF image of ab7755 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab7755, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IP
Unknown
Immunoprecipitation - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
Cytokeratin 19 was immunoprecipitated using 0.5mg HepG2 whole cell extract, 5µg of Mouse monoclonal to Cytokeratin 19 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, HepG2 whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab7755.
Secondary : Goat polyclonal to mouse IgG light chain specific (HRP) at 1/5000 dilution.
Band : 44kDa : Cytokeratin 19
All lanes:
Immunoprecipitation - Anti-Cytokeratin 19 antibody [BA-17] (ab7755)
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
All lanes:
Western blot - Anti-Cytokeratin 19 antibody [BA-17] (ab7755) at 5 µg/mL
Lane 1:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
SW480 (Human colon adenocarcinoma cell line) Whole Cell Lysate at 10 µg
Lane 3:
MDA-MB-361 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 44 kDa
Observed band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
All lanes:
Western blot - Anti-Cytokeratin 19 antibody [BA-17] (ab7755)
All lanes:
Cell lysates prepared from human MCF-7 cells
Predicted band size: 44 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CK19 plays a role in maintaining the cytoskeletal framework that provides mechanical support and helps control cell size and shape. It is not part of a large protein complex but works closely with other cytokeratins to ensure the stability and resilience of epithelial tissues. The A53-B/A22.26 positive staining is often used to confirm its presence in clinical histopathology.
Pathways
CK19 connects to cellular processes especially involving the keratinization and epithelial cell differentiation pathways. It interacts with other cytokeratins including BA16 and KR17 to facilitate these processes. This interaction aids in modulating the dynamics of cytoskeletal rearrangement during cell movement division and differentiation.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (28)
Recent publications for all applications. Explore the full list and refine your search
Proceedings of the National Academy of Sciences of the United States of America 122:e2426218122 PubMed40591600
2025
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 30:1-8 PubMed40476159
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 47:170-180 PubMed39906644
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of endocrinological investigation 48:653-670 PubMed39453570
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature cancer 4:1362-1381 PubMed37679568
2023
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 13:898-911 PubMed36929584
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & medicine 20: PubMed36971107
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:1074 PubMed36572673
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell adhesion & migration 16:13-24 PubMed35137648
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell biochemistry and function 38:817-825 PubMed32515027
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com